Ballentine Partners’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-7,235
Closed -$209K – 1195
2026
Q2
$209K Buy
+7,235
New +$195K ﹤0.01% 992

Other funds holding LEGN

Ballentine Partners's LEGN Position: Q3 2026 in Review

Ballentine Partners sold out of Legend Biotech (LEGN) in Q3 2026, closing a stake of 7,235 shares — an estimated $209K sold.

Ballentine Partners first reported a position in LEGN in Q2 2026 and held it in 1 quarter. The position peaked at $209K in Q2 2026. 197 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • Ballentine Partners reported no remaining Legend Biotech position as of Q3 2026 after selling out during the quarter.
  • Ballentine Partners sold 7,235 Legend Biotech shares in Q3 2026, an estimated $209K.
  • Ballentine Partners first reported a position in Legend Biotech in Q2 2026 and held it in 1 quarter.
  • Ballentine Partners's Legend Biotech position peaked at $209K in Q2 2026.
  • 197 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on Ballentine Partners's 13F filing for Q3 2026, filed 13 Nov 2026.